• Publications
  • Influence
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
BACKGROUND Newly discovered circulating peptides, N-terminal pro-brain natriuretic peptide (N-BNP) and adrenomedullin (ADM), were examined for prediction of cardiac function and prognosis andExpand
  • 711
  • 19
  • PDF
Plasma brain natriuretic peptide in assessment of acute dyspnoea
Recognition of heart failure (HF) may be difficult in patients presenting with acute dyspnoea, particularly in the presence of chronic airways obstruction. Since increased secretion of the cardiacExpand
  • 513
  • 15
Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment
Human brain natriuretic peptide‐32 (BNP) (i.e. proBNP(77–108)), the mature form of BNP and secreted predominantly by the cardiac ventricle, is formed from a high molecular weight precursor,Expand
  • 523
  • 13
Bioactivity and metabolism of C-type natriuretic peptide in normal man.
C-Type natriuretic peptide (CNP) is a recently identified member of the natriuretic peptide family with potent vasodepressor activity in experimental animals. Specific CNP receptors and geneExpand
  • 178
  • 9
The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma.
Using an antiserum raised in rabbits to a synthetic human brain natriuretic peptide (BNP) N-terminal fragment [ProBNP(1-13)], a single large molecular weight (MW) N-terminal form of ProBNP has beenExpand
  • 225
  • 8
Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
CONTEXT C-type natriuretic peptide (CNP) is an important regulator of skeletal growth. Loss-of-function mutations affecting the CNP receptor natriuretic peptide receptor-B (gene NPR2) cause theExpand
  • 155
  • 7
Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II
Aim: To determine the renal, endocrine and haemodynamic effects of an orally active inhibitor of the neutral endopeptidase EC 3.4.24.11 in essential hypertension Methods: Two groups of 12 white maleExpand
  • 136
  • 7
Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.
The disappearance and metabolic clearance rate (MCR) of alpha human atrial natriuretic peptide (alpha h-ANP) has been studied in normal man by radioimmunoassay of the atrial peptide in plasma andExpand
  • 250
  • 6
Outpatient screening tests for primary aldosteronism.
  • P. Dunn, E. Espiner
  • Medicine
  • Australian and New Zealand journal of medicine
  • 1 April 1976
The assessment of basal plasma aldosterone and renin concentrations, and urinary aldosterone excretion has been compared with their values after a suppressive test employing mineralocorticoid inducedExpand
  • 126
  • 6
Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload
Cardiac natriuretic peptides, especially amino terminal pro–Brain Natriuretic Peptide (NT-proBNP), are emerging as powerful circulating markers of cardiac function. However, the in vivo secretion andExpand
  • 194
  • 6
  • PDF
...
1
2
3
4
5
...